Overview
Pearson syndrome (also known as Pearson marrow-pancreas syndrome) is a rare, severe multisystem mitochondrial disorder caused by large-scale deletions (or, less commonly, rearrangements) of mitochondrial DNA (mtDNA). It typically presents in infancy with refractory sideroblastic anemia and exocrine pancreatic dysfunction. The disease affects multiple organ systems because mitochondria are essential for energy production in virtually all cells. The bone marrow is prominently involved, leading to transfusion-dependent anemia, neutropenia, and thrombocytopenia. Vacuolization of marrow precursors and the presence of ringed sideroblasts on bone marrow examination are characteristic findings. Beyond the hematologic manifestations, Pearson syndrome causes exocrine pancreatic insufficiency with malabsorption, failure to thrive, and chronic diarrhea. The liver, kidneys, and endocrine system may also be affected, with metabolic acidosis (particularly lactic acidosis) being a common and sometimes life-threatening complication. Hepatic dysfunction, renal tubular acidosis, and insulin-dependent diabetes mellitus can develop over time. Neurological involvement may also occur, though it is more prominent in patients who survive infancy and transition to a Kearns-Sayre syndrome phenotype. The prognosis of Pearson syndrome is generally poor, with many affected children dying in infancy or early childhood due to metabolic crises, sepsis, or organ failure. Treatment is primarily supportive and includes red blood cell and platelet transfusions, pancreatic enzyme replacement therapy, bicarbonate supplementation for acidosis, and nutritional support. There is no curative therapy currently available, although hematopoietic stem cell transplantation has been explored in select cases. Patients who survive the early hematologic phase may develop features of Kearns-Sayre syndrome, including progressive external ophthalmoplegia, pigmentary retinopathy, and cardiac conduction defects.
Also known as:
Clinical phenotype terms— hover any for plain English:
Mitochondrial
Passed from mother to child through the energy-producing parts of the cell
Infantile
Begins in infancy, roughly 1 month to 2 years old
FDA & Trial Timeline
5 eventsAdvanced Reconstructive Surgery Alliance — NA
National Cancer Institute, Egypt — NA
Minovia Therapeutics Ltd. — PHASE2
Columbia University
LMU Klinikum
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Pearson syndrome.
2 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.
View clinical trials →Rare Disease Specialist
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Pearson syndrome.
Community
No community posts yet. Be the first to share your experience with Pearson syndrome.
Start the conversation →Latest news about Pearson syndrome
Disease timeline:
New recruiting trial: Global Registry and Natural History Study for Mitochondrial Disorders
A new clinical trial is recruiting patients for Pearson syndrome
New recruiting trial: North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)
A new clinical trial is recruiting patients for Pearson syndrome
New recruiting trial: Evaluate the Safety and Therapeutic Effects of a Single Intravenous Infusion (IV) of Autologous CD34+ Cells Enriched With Allogenic Placenta-derived Mitochondria in Patients With a Diagnosis of Pearson Syndrome (PS)
A new clinical trial is recruiting patients for Pearson syndrome
New trial: French National Registry of Bone Marrow Failures
Phase NA trial recruiting. Bone Marrow Failure
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Pearson syndrome
What is Pearson syndrome?
Pearson syndrome (also known as Pearson marrow-pancreas syndrome) is a rare, severe multisystem mitochondrial disorder caused by large-scale deletions (or, less commonly, rearrangements) of mitochondrial DNA (mtDNA). It typically presents in infancy with refractory sideroblastic anemia and exocrine pancreatic dysfunction. The disease affects multiple organ systems because mitochondria are essential for energy production in virtually all cells. The bone marrow is prominently involved, leading to transfusion-dependent anemia, neutropenia, and thrombocytopenia. Vacuolization of marrow precursors
How is Pearson syndrome inherited?
Pearson syndrome follows a mitochondrial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Pearson syndrome typically begin?
Typical onset of Pearson syndrome is infantile. Age of onset can vary across affected individuals.
Are there clinical trials for Pearson syndrome?
Yes — 2 recruiting clinical trials are currently listed for Pearson syndrome on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
Which specialists treat Pearson syndrome?
18 specialists and care centers treating Pearson syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.